The Nobel Prize Winner in Physiology/Medicine (1975), Prof. David Baltimore from California Institute of Technology (Caltec), California, USA, has reported in a number of prestigious journals that NFKB regulates the expression of a number of miRNAs.
In connection with Nobel Laureate Baltimore’s findings, Dr Boominathan, Founder Director-cum-chief scientist of GBMD, reports that Celastrol, an antioxidant and anti-inflammatory drug, suppresses the expression of epigenetic integrator UHRF1 via up regulation of its target gene.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Molecular cancer therapy: Celastrol, an antioxidant and anti-inflammatory drug, suppresses the expression of epigenetic integrator UHRF1 via up regulation of its target gene, 7/February/2014, 22.13, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
***********************
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Treating Cancer with Thunder of God vine: Celastrol, an antioxidant & anti-inflammatory drug from Thunder of God vine, suppresses the expression of epigenetic integrator UHRF1 via up regulation of its target gene, 10/March/2014, 12.05 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
